PharmAthene Wins Share Of SIGA Smallpox Drug Profits
A Delaware judge on Thursday granted PharmAthene Inc. a share in profits from sales of SIGA Technologies Inc.'s smallpox drug, ruling SIGA breached an agreement to negotiate a merger and licensing...To view the full article, register now.
Already a subscriber? Click here to view full article